A high prevalence of PF4/heparin antibodies has been reported in cardiosurgical and orthopedic patients, as well as in volunteer blood donors without a clinical syndrome of thrombosis/thrombocytopenia [29,35,37,38,39]. Here, PF4 is linked to deep vein thrombosis.